Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genomic and transcriptomic insights into the precision treatment of pulmonary enteric adenocarcinoma.

Lung cancer (Amsterdam, Netherlands) - 1 May 2023

Liu Yuan, Lu Tao, Yuan Mingming, Chen Rongrong, Lu Junliang, Wang Hanping, Wu Zhiyong, Wang Yingyi

Abstract excerpt

BACKGROUND: Pulmonary enteric adenocarcinoma (PEAC) is a rare subtype of lung adenocarcinoma. More investigations about precision therapy in PEAC were required to improve the prognosis. METHODS: Twenty-four patients with PEAC were enrolled in this study. Tumor tissue samples were available from 17 patients for both DNA and RNA based next-generation sequencing, PD-L1 IHC staining and PCR-based microsatellite...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma of Lung
Share to B7-H1 Antigen

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Biomarkers, Tumor

Share to ErbB Receptors

Share to Genomics

Share to Proto-Oncogene Proteins p21(ras)

Share to Receptor Protein-Tyrosine Kinases

Share to Transcriptome

Source

Identifiers

PMID: 37003209
DOI: 10.1016/j.lungcan.2023.03.005

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genomic and transcriptomic insights into the precision treatment of pulmonary enteric adenocarcinoma.PMID 37003209Read ↗

Genetic mutation profiles and immune microenvironment analysis of pulmonary enteric adenocarcinoma.Semantic proximity Read ↗

Case report: Target and immunotherapy of a lung adenocarcinoma with enteric differentiation, EGFR mutation, and high microsatellite instability.Semantic proximity Read ↗

Clinicopathological and genetic analyses of pulmonary enteric adenocarcinoma.Semantic proximity Read ↗

Genomic and epigenomic profiles distinguish pulmonary enteric adenocarcinoma from lung metastatic colorectal cancer.Semantic proximity Read ↗

Distinctive features of immunostaining and mutational load in primary pulmonary enteric adenocarcinoma: implications for differential diagnosis and immunotherapy.Semantic proximity Read ↗

Pulmonary adenocarcinoma with enteric differentiation: Dissecting oncogenic genes alterations with DNA sequencing and FISH analysis.Semantic proximity Read ↗

Gene aberrations for precision medicine against lung adenocarcinoma.Semantic proximity Read ↗

Whole genome sequencing in oesophageal adenocarcinoma unmasks potential precision therapies.Semantic proximity Read ↗

Esophageal neuroendocrine carcinoma: molecular insights, diagnostic advances, and emerging treatment strategies.Semantic proximity Read ↗

Top advances of the year: Precision oncology.Semantic proximity Read ↗

Distinct genomic landscapes of gastroesophageal adenocarcinoma depending on PD-L1 expression identify mutations in RAS-MAPK pathway and TP53 as potential predictors of immunotherapy efficacy.Semantic proximity Read ↗

MicroRNA profiling of primary pulmonary enteric adenocarcinoma in members from the same family reveals some similarities to pancreatic adenocarcinoma—a step towards personalized therapySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.